Dong-E-E-Jiao Co.,Ltd. (000423.SZ)
ValueMarkers Composite Index
69% below intrinsic value ($25)
Dong-E-E-Jiao Co.,Ltd. (000423.SZ) — VMCI valuation read
Dong-E-E-Jiao Co.,Ltd. sits at VMCI 65/100, with the Healthcare sector median at 50. That 15-point spread is the first thing to note on 000423.SZ: it tells the reader the composite is favorable before any single ratio is examined, and the mid-cap tier sets the comparison set.
Form 4 disclosures on 000423.SZ are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.
**Investor frame.** The Value read on 000423.SZ: 000423.SZ trades at 16.0x earnings, 11% below the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp. The Risk read: net debt to EBITDA of -2.2x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.
000423.SZ rose 0.1% over the trailing 7 days, with a -23.4% read on a 30-day basis.
Dong-E-E-Jiao Co.,Ltd. produces and sells traditional Chinese medicines, biological drugs, and health food products in China. Dong-E-E-Jiao Co.,Ltd. was founded in 1952 and is based in Liaocheng, China.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.